stockrow
Friday 6 November 2026
Export ENOV’s income statement to Excel — free account
Enovis Corporation
ENOV Healthcare Medical Devices
Enovis Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.2 billion, up 6.66% from fiscal 2024.
- Revenue
- +1.79%
- EPS
- +100.6%
- Free cash flow
- +20.3%
- Total debt
- −7.45%
Quarter to September 2026, against a year earlier
27.07
1.55
−5.42%
Follow ENOV
Alert me
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
35.48 | 32.64 | 17.86 | 0.00 | 123.34 | 95.76 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
6 | 7 | 5 | 5 | 7 | 8 | 3 | 5 | 3 | 4 |
P/S ratio |
1.42 | 2.53 | 1.15 | 1.48 | 4.67 | 4.95 | 1.88 | 1.77 | 1.15 | 0.68 |
Altman Z-Score |
1.72 | 1.69 | 1.24 | 1.48 | 1.14 | 1.52 | 2.67 | 2.32 | 0.65 | (0.34) |
P/FCF ratio |
23.75 | 28.65 | 13.12 | 370.44 | 26.59 | 27.24 | 0.00 | 66.64 | 0.00 | 76.33 |
Altman Z″-Score (non-manufacturers) |
2.31 | 2.81 | 2.56 | 1.82 | 1.66 | 2.43 | 5.08 | 4.36 | 0.81 | (1.51) |
Beneish M-Score |
(2.61) | (2.23) | (3.00) | (2.31) | (1.88) | (3.09) | (2.19) | (2.72) | (3.50) | (4.29) |
P/Operating CF |
31.25 | 47.14 | 20.02 | 75.72 | 40.60 | 73.30 | (81.79) | 44.16 | 27.46 | 17.17 |
P/B ratio |
1.47 | 1.32 | 0.72 | 1.41 | 1.46 | 1.51 | 0.85 | 0.88 | 0.95 | 1.02 |
Price to Tangible BV |
0.00 | 28.61 | 1.86 | 0.00 | 0.00 | 4.48 | 8.27 | 13.00 | 0.00 | 0.00 |
EV/Sales |
1.76 | 2.87 | 1.66 | 2.15 | 6.57 | 5.93 | 2.03 | 2.03 | 1.76 | 1.24 |
EV/EBITDA |
14.78 | 12.30 | 12.09 | 16.24 | 40.90 | 42.27 | 21.38 | 22.93 | 23.26 | 12.65 |
EV/Operating CF |
22.75 | 25.40 | 16.05 | 54.52 | 24.39 | 23.75 | (56.86) | 25.72 | 32.66 | 12.80 |
EV/FCF |
29.42 | 32.45 | 18.97 | 535.69 | 37.44 | 32.67 | (20.03) | 76.59 | (55.16) | 139.62 |
Quick Ratio |
0.99 | 1.26 | 0.39 | 0.78 | 0.76 | 0.91 | 0.52 | 0.89 | 0.86 | 0.80 |
Current Ratio |
1.64 | 1.89 | 1.63 | 1.64 | 1.68 | 2.25 | 1.41 | 2.43 | 2.17 | 2.02 |
Net Debt/EBITDA |
2.85 | 1.44 | 3.73 | 5.01 | 11.85 | 7.03 | 1.58 | 2.84 | 8.04 | 5.73 |
Debt/Assets |
20.39% | 15.81% | 18.10% | 31.30% | 30.35% | 24.50% | 6.07% | 10.34% | 28.17% | 33.82% |
Debt/Equity |
0.42 | 0.28 | 0.34 | 0.66 | 0.62 | 0.45 | 0.08 | 0.14 | 0.52 | 0.87 |
Asset Turnover |
0.49 | 0.30 | 0.33 | 0.48 | 0.15 | 0.18 | 0.24 | 0.39 | 0.46 | 0.53 |
Operating CF/Net income |
1.93 | 1.45 | 1.61 | (0.25) | 7.08 | 4.97 | 4.20 | (4.06) | (0.14) | (0.18) |
Capex/Depreciation |
(0.39) | (0.15) | (0.23) | (0.50) | (0.43) | (0.37) | (0.47) | (0.41) | (0.19) | (0.15) |
Interest Coverage |
7.82 | 3.38 | 3.09 | 1.70 | (1.25) | (2.16) | (2.96) | (3.33) | (13.59) | (32.28) |
| 4.04% | 4.43% | 3.89% | (15.15%) | 1.20% | 1.74% | (0.33%) | (0.97%) | (27.59%) | (58.40%) | |
| 1.96% | 2.32% | 2.10% | (7.54%) | 0.58% | 0.90% | (0.21%) | (0.76%) | (17.89%) | (27.69%) | |
ROIC |
3.54% | 1.94% | 2.06% | 2.24% | (0.72%) | (0.65%) | (1.21%) | (1.07%) | (12.61%) | (25.53%) |
Return on Tangible Assets |
10.82% | 9.91% | 12.91% | (50.82%) | 4.11% | 4.73% | (2.85%) | (4.17%) | (80.78%) | (106.17%) |
Average Days of Receivables |
96.10 | 182.79 | 64.34 | 61.63 | 168.38 | 65.25 | 62.44 | 62.32 | 70.49 | 71.89 |
Research and Development Expense of Revenue |
1.22% | 2.22% | 1.55% | 1.86% | 3.06% | 3.44% | 3.89% | 4.41% | 4.33% | 5.35% |
Selling, General and Administrative Expense of Revenue |
21.87% | 25.84% | 25.02% | 34.02% | 46.00% | 46.68% | 49.45% | 48.64% | 48.74% | 47.60% |
Intangible Assets out of Total Assets |
0.52 | 0.53 | 0.32 | 0.67 | 0.68 | 0.36 | 0.72 | 0.71 | 0.64 | 0.51 |
Share Based Compensation of Revenue |
0.60% | 1.11% | 1.14% | 0.66% | 2.58% | 2.48% | 2.49% | 2.00% | 1.41% | 1.46% |
Graham Net Nets |
(0.33) | (0.19) | (0.47) | (0.50) | (0.46) | (0.22) | (0.01) | (0.06) | (0.42) | (0.75) |
Graham Number |
72.81 | 86.45 | 82.76 | 0.00 | 40.58 | 54.35 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
2.82% | 3.06% | 5.60% | (10.67%) | 0.81% | 1.04% | (0.35%) | (1.10%) | (32.57%) | (77.74%) |
Free Cash Flow Yield |
4.21% | 3.49% | 7.62% | 0.27% | 3.76% | 3.67% | (5.39%) | 1.50% | (2.77%) | 1.31% |
Revenue per Share |
77.76 | 47.17 | 54.70 | 73.56 | 24.58 | 27.89 | 28.91 | 31.33 | 38.13 | 39.39 |
Operating CF per Share |
6.03 | 5.33 | 5.65 | 2.89 | 6.62 | 6.96 | (1.03) | 2.48 | 2.05 | 3.81 |
Capex per Share |
(1.37) | (1.16) | (0.87) | (2.60) | (2.31) | (1.90) | (1.90) | (1.65) | (3.27) | (3.46) |
Free Cash Flow per Share |
4.66 | 4.17 | 4.78 | 0.29 | 4.31 | 5.06 | (2.93) | 0.83 | (1.22) | 0.35 |
Cash per Share |
5.10 | 10.02 | 1.92 | 2.42 | 2.13 | 13.30 | 0.45 | 0.66 | 0.87 | 0.64 |
Shareholders Equity per Share |
75.51 | 90.75 | 86.72 | 77.15 | 78.70 | 91.15 | 63.81 | 62.77 | 46.39 | 26.14 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
75.51 | 90.75 | 86.72 | 77.15 | 78.70 | 91.15 | 63.81 | 62.77 | 46.39 | 26.14 |
Free Cash Flow |
190.97 | 171.23 | 191.55 | 13.33 | 196.70 | 258.90 | (158.56) | 45.34 | (67.21) | 19.92 |
Working Capital |
678.92 | 972.45 | 759.10 | 546.93 | 550.17 | 1,279.70 | 229.82 | 526.91 | 617.45 | 608.59 |
Capital Expenditures |
(56.00) | (47.54) | (34.82) | (117.62) | (105.23) | (97.20) | (102.70) | (89.65) | (180.71) | (197.38) |
Net Current Asset Value |
(1,506.52) | (912.60) | (1,180.57) | (2,492.96) | (2,401.85) | (1,551.20) | (28.42) | (192.11) | (1,008.00) | (1,135.78) |
EV/EBIT |
23.73 | 40.97 | 23.98 | 35.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.04 | 0.09 | 0.07 | 0.07 | 0.05 | 0.09 | 0.09 |
Price to Operating Income |
19.15 | 36.18 | 16.59 | 24.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.28 | 0.57 | 0.46 | 0.48 | 0.51 | 1.12 | 0.93 | 0.80 | 2.31 | 2.65 |
Cash ROIC |
4.16% | 3.29% | 4.03% | 0.23% | 3.32% | 3.49% | (4.25%) | 1.16% | (1.70%) | 0.71% |
Accounts Receivable Turnover |
3.69 | 2.14 | 3.23 | 7.02 | 2.08 | 3.70 | 5.99 | 6.11 | 6.03 | 5.29 |
Accounts Payable Turnover |
4.04 | 2.30 | 3.33 | 5.92 | 1.50 | 2.67 | 4.77 | 5.34 | 5.95 | 4.92 |
Inventory Turnover |
5.59 | 3.19 | 3.71 | 4.14 | 0.91 | 1.41 | 1.77 | 1.60 | 1.82 | 1.60 |
Average Days of Payables |
85.79 | 169.31 | 72.62 | 68.17 | 233.13 | 87.36 | 71.36 | 67.49 | 70.53 | 75.82 |
Days of Inventory on Hand |
60.74 | 123.89 | 89.69 | 108.29 | 398.72 | 200.50 | 224.48 | 238.86 | 215.46 | 236.27 |
Average Receivables |
863.48 | 904.50 | 678.39 | 474.23 | 539.44 | 385.98 | 261.17 | 279.43 | 349.26 | 424.91 |
Average Payables |
542.48 | 551.32 | 439.18 | 325.51 | 345.02 | 242.73 | 145.42 | 134.05 | 155.79 | 183.31 |
Average Inventory |
392.68 | 397.30 | 394.64 | 465.61 | 568.19 | 460.53 | 391.44 | 447.74 | 507.98 | 565.75 |
Average Assets |
6,535.68 | 6,524.07 | 6,662.83 | 7,001.40 | 7,369.19 | 7,933.73 | 6,394.58 | 4,391.29 | 4,614.06 | 4,276.76 |
Average Common Equity |
3,174.95 | 3,410.30 | 3,602.11 | 3,483.29 | 3,538.75 | 4,124.65 | 4,055.62 | 3,435.25 | 2,992.52 | 2,028.12 |
Columns are period end dates · fundamentals updated 5 Nov 2026